-
May 2, 2025
Review
New
Considerations for Non-Clinical Studies in the Development of Diagnostic Radiopharmaceuticals (Early Consideration) posted
-
April 28, 2025
Review
New
English Translation of Review Report: Akuugo
-
April 18, 2025
Review
“Initiatives to Promote Pediatric Drug Development” posted
-
April 14, 2025
Review
Information on biosimilars is updated
-
April 11, 2025
Review
List of Approved Products (New Drugs): April 2004 to December 2024
-
April 4, 2025
Review
English Translation of Review Report: Awiqli
-
April 4, 2025
Review
English translation of review report: SENTINEL Cerebral Protection System
-
March 14, 2025
Review
The information of New Drug Review with Electronic Data updated
-
March 4, 2025
Review
Regenerative Medical Products Information posted
-
March 3, 2025
Review
List of Approved Products: April 2015 to September 2024
-
February 28, 2025
Int
The new website “For Industry - for development in Japan “ launched.
-
February 25, 2025
Review
List of Approved Products (Medical Devices): April 2004 to September 2024
-
February 17, 2025
Review
Consideration in the development of drugs for pulmonary arterial hypertension (Early Consideration) posted
-
February 7, 2025
Review
GMP / GCTP Annual Report FY 2023 posted
-
December 17, 2024
Review
Check List for 30-day-Clinical Trial Notification Review on an Initial Clinical Trial Notification (Oncology Drugs)
-
August 23, 2024
Review
PMDA’s Support to Venture Companies posted
-
June 21, 2024
Review
GMP compliance inspection updated
-
May 30, 2024
Review
Pamphlet of Regulatory Science Consultations is posted
-
September 26, 2023
Review
GMP Compliance Inspection concerning Drugs and Quasi-drags of Foreign Manufacturers
-
May 9, 2023
Review
Regulations Regarding Living Modified Organisms (Genetically Modified Organisms) posted
-
January 25, 2023
Review
Ministerial Ordinance on Good Clinical Practice for Drugs updated
-
September 16, 2021
Review
Q&A on the Master File (MF) System, Part III posted
-
June 12, 2015
Review
The Pilot Project in The Last Half of FY2014 (Outline and results)